We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
If you are manufacturing, importing or supplying MDMA and psilocybine products for therapeutic use in Australia, there are rules you must follow.
As MDMA and psilocybine are unapproved therapeutic goods, they can be legally supplied through clinical trials or by an authorised psychiatrist under the Authorised Prescriber Scheme.
You are responsible for ensuring that an exemption or authorisation is in place before supplying these products.
You must meet certain obligations to legally supply therapeutic goods in Australia. This section contains guidance and information specific to unapproved therapeutic goods. You may also have to meet obligations that apply to all unapproved therapeutic goods and all products.